Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMNN stock hub

Imunon, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

IMNNis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
10.7M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
IMNN
In the news

Latest news · IMNN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.6P50 18.3P75 33.7
Trailing P/En/a
P25 15P50 23.3P75 38.5
ROE-256.4
P25 -106.6P50 -46.9P75 -3.1
ROIC-136.1
P25 -63.1P50 -27.5P75 -0
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All IMNN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
188
Groups with data
11
Currency
USD
Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0000749647
Company name
Imunon, Inc.
Country
United States
Country code
US
Cusip
15117N701
Employees
25
Employees Change
-8%
Employees Change Percent
-24.24
Enterprise value
$2.9M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
1985-03-05
Isin
US15117N7012
Last refreshed
2026-05-10
Market cap
$10.7M
Market cap category
Nano-Cap
Price
$2.72
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
IMNN
Website
https://imunon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-135.85%
FCF yield
-132.87%
P/B ratio
1.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-14.5M
Net Income Growth Years
3%
Profit Per Employee
$-579,801
ROA
-83.22
Roa5y
-49.73
ROCE
-191.2
ROE
-256.4
Roe5y
-139.8
ROIC
-136.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr10y
-51.94%
Cagr15y
-46.77%
Cagr1y
-74.59%
Cagr20y
-38.89%
Cagr3y
-46.73%
Cagr5y
-58.05%
EPS Growth Quarters
12
EPS Growth Years
3
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$12.3M
Cash
$8.8M
Current Assets
$10.7M
Current Liabilities
$4.6M
Debt
$1M
Debt Equity
$0.14
Equity
$7.1M
Liabilities
$5.2M
Long Term Assets
$1.6M
Long Term Liabilities
$602,411
Net Cash
$7.8M
Net Cash By Market Cap
$72.84
Net Cash Growth
64.2%
Net Debt Equity
$-1.1
Tangible Book Value
$7.1M
Tangible Book Value Per Share
$2.07
WACC
14.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
2.32
Net Working Capital
$-2.3M
Quick ratio
1.9
Working Capital
$6.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-93.23%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

42
MetricValue
10Y total return
-99.93%
1Y total return
-74.57%
200-day SMA
4.24
3Y total return
-84.89%
50-day SMA
2.99
50-day SMA vs 200-day SMA
50under200
5Y total return
-98.7%
All Time High
1,895,059.9
All Time High Change
-100%
All Time High Date
2000-03-03
All Time Low
2.52
All Time Low Change
7.94%
All Time Low Date
2026-03-25
ATR
0.18
Beta
2.03
Beta1y
-2.92
Beta2y
-0.76
Ch YTD
-28.61
High
2.76
High52
41.22
High52 Date
2025-06-02
High52ch
-93.4%
Low
2.7
Low52
2.52
Low52 Date
2026-03-25
Low52ch
7.94%
Ma50ch
-8.97%
Premarket Change Percent
1.47
Premarket Price
$2.77
Premarket Volume
170
Price vs 200-day SMA
-35.88%
RSI
38.31
RSI Monthly
38.01
RSI Weekly
37.14
Sharpe ratio
0.07x
Sortino ratio
0.27
Total Return
-93.23%
Tr YTD
-28.61
Tr15y
-99.99%
Tr1m
-12.82%
Tr1w
-2.86%
Tr3m
-16.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Analyst Count
2
Analyst Ratings
Buy
Earnings EPS Estimate
$-1.22
Operating Income
$-14.7M
Price target
$10
Price Target Change
$268

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
3,539,060%
Float Percent
90.22%
Shares Insiders
0.86%
Shares Institutions
5.7%
Shares Out
3,922,764
Shares Qo Q
-0.61%
Shares Yo Y
93.23%
Short Float
4.02%
Short Ratio
0.72
Short Shares
3.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
$-14.4M
Average Volume
35,531.1x
Bv Per Share
2.07
CAPEX
$-280,572
Ch10y
-99.93
Ch15y
-99.99
Ch1m
-12.82
Ch1w
-2.86
Ch1y
-74.57
Ch20y
-99.99
Ch3m
-16.82
Ch3y
-84.89
Ch5y
-98.7
Ch6m
-32
Change
-0.37%
Change From Open
-1.45
Close
2.73
Days Gap
1.1
Depreciation Amortization
291,908
Dollar Volume
51,538
Earnings Date
2026-05-12
Earnings Time
bmo
EBIT
$-14.7M
EBITDA
$-14.4M
EPS
$-6.83
F Score
2
FCF
$-14.2M
FCF EV Yield
-489.27x
FCF Per Share
$-3.61
Financing CF
17,085,488
Fiscal Year End
December
Founded
1,982
Investing CF
-280,572
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-31
Last Report Date
2025-12-31
Last Split Date
2025-08-07
Last Split Type
Forward
Last10k Filing Date
2026-03-31
Ma150
3.62
Ma150ch
-24.9%
Ma20
2.89
Ma20ch
-5.85%
Net CF
2,908,292
Next Earnings Date
2026-05-12
Open
2.76
Optionable
No
Position In Range
33.33
Post Close
2.72
Postmarket Change Percent
1.23
Postmarket Price
$2.75
Ppne
1,514,372
Pre Close
2.73
Price Date
2026-05-08
Ptbv Ratio
1.51
Relative Volume
0.53x
Share Based Comp
226,414
Tr20y
-99.99%
Tr6m
-32%
Us State
New Jersey
Volume
18,947.8
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does IMNN pay a dividend?

Capital-return profile for this ticker.

Performance

IMNN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-74.6%
S&P 500 1Y: n/a
3Y total return
-84.9%
S&P 500 3Y: n/a
5Y total return
-98.7%
S&P 500 5Y: n/a
10Y total return
-99.9%
S&P 500 10Y: n/a
Ownership

Who owns IMNN?

Insider, institutional, and short-interest positioning.

Institutional ownership
+5.7%
Float: +90.2% of shares outstanding
Insider ownership
+0.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+4.0%
0.7 days to cover
Y/Y dilution
+93.2%
Negative means the company is buying back shares.
Technical

IMNN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.3
Neutral momentum band
Price vs 200-day MA
-35.9%
50/200-day relationship not available
Beta (5Y)
2.03
More volatile than the market
Sharpe ratio
0.07
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About IMNN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMNN stock rating?

Imunon, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMNN analysis?

The full report lives at /stocks/IMNN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMNN?

The latest report frames IMNN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMNN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.